New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
16:22 EDTAGN, VRX, EMC, YUM, MNST, MCD, VMW, EXTROn The Fly: Closing Wrap
Stocks on Wall Street began the trading day in negative territory and remained there through nearly the whole session. The market action was influenced more by the geopolitical events in Russia and Israel than by the upcoming avalanche of earnings scheduled for release throughout the week. Despite the weak open and subsequent drop during the first hour of trading, the market drifted off its lows and managed to pare its losses, even turning mixed for a short time. The averages dipped again heading into the bell, though they closed well of their worst levels. ECONOMIC EVENTS: In the U.S., the Chicago Fed's National Activity Index dipped to 0.12 in June from a reading of 0.16 in May. COMPANY NEWS: Allergan (AGN) rose $3.74, or 2.23%, to $171.14 after the company's Q2 results and its FY14 outlook beat expectations. The company, which is working to fend off a proposed acquisition by Valeant Pharmaceuticals (VRX), also announced plans to cut its workforce by 13%, or about 1,500 employees, as part of a broader restructuring effort. In related news, Valeant announced it has contacted both the SEC and Canadian financial authorities regarding Allergan's "apparent attempt to mislead investors and manipulate the market for Valeant common shares by continuing to make false and misleading statements regarding Valeant's business." Later in the day, Bill Ackman of Pershing Square, who is partnering with Valeant in its attempt to buy Allergan, called the restructuring a "Valeant light" effort and said Valeant does not need to raise its bid for Allergan. Ackman explained that he believes that shares of Valeant will rise around $10 should the Allergan board engage in takeover talks with the company and that a $10 share rise would boost Valeant's bid for Allergan by $8 per share. MAJOR MOVERS: Among the notable gainers was Extreme Networks (EXTR), which rose 69c, or 15.79%, to $5.06 after the company raised its Q4 earnings per share outlook and narrowed its Q4 revenue view. Also higher were shares of EMC (EMC), which advanced $1.35, or 5.0%, to $28.33 after the Wall Street Journal reported, citing sources, that activist investor Elliott Management has taken a stake of over $1B in the data-storage company and plans to push it to break itself up and spin off VMware (VMW), which is 80% owned by EMC. Shares of VMware fell $2.36, or 2.48%, to $92.95 following the Journal's report. Among the other noteworthy losers was Monster Beverage (MNST), which fell $3.07, or 4.53%, to $64.74 after Morgan Stanley downgraded the stock, citing slowing U.S. trends and balanced valuation. Also lower were shares of Yum! Brands (YUM), which fell $3.29, or 4.25%, to $74.13 after Associated Press reported that the company's KFC brand and McDonald's (MCD) were sold expired beef and chicken in China from food supplier Husi Food. Shares of McDonald's, which is scheduled to report on its quarter before tomorrow's market open, slid $1.44, or 1.45%, to $97.55. INDEXES: The Dow fell 48.45, or 0.28%, to 17,051.73, the Nasdaq dropped 7.44, or 0.17%, to 4,424.70, and the S&P 500 declined 4.59, or 0.23%, to 1,973.63.
News For AGN;VRX;EMC;YUM;MNST;MCD;VMW;EXTR From The Last 14 Days
Check below for free stories on AGN;VRX;EMC;YUM;MNST;MCD;VMW;EXTR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 10, 2014
09:38 EDTMCDActive equity options trading on open
Subscribe for More Information
September 9, 2014
19:39 EDTVMWVMware initiated with a Buy at Maxim
Target $120.00.
16:23 EDTMCDOn The Fly: Closing Wrap
Subscribe for More Information
16:04 EDTAGNPershing Square reports 9.7% stake in Allergan, sends letter to board
Pershing Square Capital Management sent a letter to the board of Allergan that highlights several reasons why Allergan is extremely shareholder unfriendly and why now is the time for Allergan's management team to wake up. In the letter, Pershing Square said: "Since the bid was announced in April, 75% of Allergan’s shareholders have sold all or a portion of their investment including the company’s largest shareholder, which has sold its entire position. These shareholders are sending the board a message. They would not have sold if they believed that Allergan stock was worth more than current values... We note CFO Jeff Edwards recent decision to retire from the company at age 53 for family reasons, and his replacement by an investor relations executive rather than an experienced public company CFO. The notion that Allergan should execute the largest acquisition in its history led by an investor relations executive is a frightening proposition. While we respect an executive’s need to retire from a company for family reasons, Edwards exit also calls into question the company’s forward earnings guidance which shareholders expected him to execute on when the Company presented these projections on July 21st. I had expected that at some point one or more directors would have woken up and smelled the coffee. There is still time for a subset of directors to rescue their reputations by taking over leadership of this process from David Pyott and his handpicked advisors and doing what you are paid $400,000 per year to do on behalf of the company’s owners."
14:54 EDTMCDApple announces Apple Pay
Subscribe for More Information
12:10 EDTMCDOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday after opening in the red and trading in a narrow range throughout the morning. The domestic economic calendar only had two reports of consequence, and neither was particularly market moving. All eyes are on Cupertino, California, where Apple (AAPL) will shortly begin its much-anticipated product launch event. ECONOMIC EVENTS: In the U.S., the NFIB small business optimism survey for August came in at 96.1, which was above the expected 96.0 reading. The Job Openings and Labor Turnover Survey, or JOLTS report, showed job openings slipped 2K to about 4.67M in July. COMPANY NEWS: Shares of Apple were up 1% near noon ahead of the tech giant's latest product launch event, which is scheduled to begin at 1 pm ET. Expectations are for the company to introduce the iPhone 6, which has widely been speculated to be bigger than past members of the line-up and may come in 4.7 inch and 5.5 inch sizes. The company is also expected to unveil a wearable device, likely a smartwatch, and a mobile payment system integrated with both... Shares of fast food giant McDonald’s (MCD) slid 1% after reporting its comparable sales were down 3.7% worldwide in August and that its China supplier issue will negatively impact its Q3 EPS by 15c-20c. MAJOR MOVERS: Among the notable gainers was Annies (BNNY), which surged 38% after prepared foods giant General Mills (GIS) last night said that it had agreed to buy the mac and cheese maker for $820M, or $46 per share in cash. Shares of a number of other natural food makers climbed after the deal, as WhiteWave (WWAV) rose nearly 3% and Boulder Brands (BDBD) jumped over 8%. Following the deal announcement, shares of General Mills slipped about 0.5%. Among the noteworthy losers was Leidos (LDOS), which dropped 15% after the company reported lower than expected second quarter earnings and cuts its EPS view for the fiscal year. Also lower was MaxLinear (MXL), which fell 15% after the company said several of its cable and satellite customers have requested push-outs of shipments, resulting in the company lowering its Q3 revenue outlook and Needham downgrading the stock to Buy from Strong Buy. INDEXES: Near midday, the Dow was down 69.02, or 0.4%, to 17,042.40, the Nasdaq was down 14.93, or 0.33%, to 4,577.35, and the S&P 500 was down 6.74, or 0.34%, to 1,994.80.
10:45 EDTMCDMcDonald's hits fresh 52-week low, levels to watch
Subscribe for More Information
09:36 EDTMCDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL KNDI NFLX YHOO TWTR TSLA C BAC FB MCD
09:12 EDTMCDOn The Fly: Pre-market Movers
Subscribe for More Information
08:00 EDTMCDMcDonald's: China supplier issue to negatively impact Q3 by 15c-20c
This is largely due to a combination of lost sales, expenses associated with our recovery efforts and the impact of these items on the third quarter tax rate, which is expected to be above the company's outlook for the full-year tax rate of 31-33%.
07:59 EDTMCDMcDonald's CEO: McDonald's global business faced several headwinds
Subscribe for More Information
07:58 EDTMCDMcDonald's reports August global comparable sales down 3.7%
Subscribe for More Information
07:05 EDTEMCEMC Corporation to hold a summit
Subscribe for More Information
06:42 EDTAGN, VRXLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
05:36 EDTEMC, VMWVMware, Capgemini announce strategic partnership
Subscribe for More Information
September 8, 2014
17:01 EDTVRXValeant to expand Bausch + Lomb facility, will add 120 new jobs
Valeant Pharmaceuticals announced that the company hosted a ribbon cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY. The ceremony recognized the expansion and installation of the new manufacturing lines, which will produce the company's silicone hydrogel contact lens, Bausch + Lomb ULTRA. The solar array, which is currently under construction, will generate and supply electricity through the installation of 3,667 solar panels, helping to reduce the Rochester facility's carbon footprint by 800 tons of carbon dioxide emissions annually.
15:43 EDTMNSTMonster Beverage asks court to block NY probe subpoena, Bloomberg says
Subscribe for More Information
09:40 EDTMCDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TWTR TSLA YHOO BAC FB MSFT NFLX GILD MCD
08:45 EDTEMCNimble Storage, Arista, CommVault recommnded on M&A at Pacific Crest
Subscribe for More Information
07:21 EDTAGNJazz looks more attractive for Allergan than Salix, says Wells Fargo
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use